VanEck Lists VAVX Avalanche ETF on Nasdaq With Staking Yield Included
VanEck has launched the VanEck Avalanche ETF (ticker: VAVX) on Nasdaq, offering U.S. investors regulated, spot-based exposure to AVAX without self-custody. The ETF integrates staking rewards into its NAV, with an initial estimated net staking yield around 5.3%. VanEck may stake a portion of holdings through Coinbase Crypto Services, which charges a 4% service fee; staking exposes the fund to slashing and liquidity risks. VanEck waived sponsor/management fees on the first $500 million of assets until February 28, 2026; a 0.20% sponsor fee applies thereafter. The product is structured to make institutional access easier for RIAs, wealth managers and institutions and follows 2025 regulatory changes that eased approvals for altcoin spot ETFs. AVAX was trading near $11.70–$11.80 in late January 2026, with circulating supply above 431 million and market cap near $5 billion. The launch could encourage other AVAX spot-ETF conversions and filings (e.g., Grayscale, Bitwise). Key risks for traders include AVAX price volatility, staking risks (slashing, lockups, third-party service fees), and regulatory shifts that could affect fund operations or listing rules.
Bullish
The ETF launch is likely bullish for AVAX price over the medium term because it lowers institutional frictions to ownership and creates a regulated, on‑ramp product that can attract RIA, wealth manager and institutional inflows. Inclusion of staking yield (net ~5.3%) makes the offering more attractive relative to pure spot exposure, potentially increasing demand. Fee waivers on the first $500M can accelerate early asset gathering and visibility. In the short term, the price may see modest upside from listing-related flows and marketing, but the impact could be limited if inflows are slow or if market sentiment is weak. Downside risks that temper the bullish view include AVAX’s inherent volatility, staking-specific risks (slashing, lockups, counterparty fees via Coinbase), and possible future regulatory actions that could restrict ETF operations or reduce investor appetite. Overall, the product increases the probability of sustained institutional demand, so the net directional effect on AVAX is positive.